LNTH•benzinga•
CytoSite Bio Announces Agreement With Lantheus For Granzyme B Targeted PET Imaging Radiotracer For Immunotherapy Assessment; CytoSite Will Lead Initial Clinical Development With Lantheus Having An Exclusive Option To Acquire Worldwide Development And Comm
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 26, 2025 by benzinga